A long-term study to evaluate the increase in inducible interferon-γ protein 10 during treatment with nucleostide analogues in chronic hepatitis B.
Phase of Trial: Phase IV
Latest Information Update: 24 Dec 2015
At a glance
- Drugs Entecavir (Primary) ; Tenofovir (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics
- 24 Dec 2015 New trial record